Article
Contezolid Harbored Equivalent Efficacy to Linezolid in Tuberculosis Treatment in a…
Infection and Drug Resistance · 2025 · Jiang G, Liu R, Xue Y, Ge Q, Nie L, Lv Z, Kong Z, Shi J, Chen H, Li H, Wu X, Xie L, Song Y, Huang H, Gao M
Key facts
| Title | Contezolid Harbored Equivalent Efficacy to Linezolid in Tuberculosis Treatment in a Prospective and Randomized Early Bactericidal Activity Study |
|---|---|
| First author | Jiang G, Liu R, Xue Y, Ge Q, Nie L, Lv Z, Kong Z, Shi J, Chen H, Li H, Wu X, Xie L, Song Y, Huang H, Gao M |
| Journal | Infection and Drug Resistance |
| Published | Jan 13, 2025 |
| DOI | 10.2147/IDR.S499816 |
| Devices mentioned | DEN070004, DEN130032, K002165, K014123, K021582, K060540, K070462, K080837, K082118, K082140, K091109, K092953 and 58 more |
| Product codes mentioned | CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, JTN, KLB and 32 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1